FDA Recommendation For Liver Cancer Treatment
On March 10, the Food and Drug Administration (FDA) recommended a union of the checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) for people with exceptional…
On March 10, the Food and Drug Administration (FDA) recommended a union of the checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) for people with exceptional…